Clinical Trial Update: FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV

View source ↗

Summary

This completed trial evaluated FiO2 in COPD patients treated with normobaric oxygen versus noninvasive ventilation in a home-care setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Breas Medical S.A.R.L. | Conditions: COPD, Home Care | Status: COMPLETED